In this interview, the Managing Director of Cooper Metals (ASX:CPM) discusses the company's active drilling program in the Mount Isa region, targeting copper and gold prospects. They highlight their methodical approach to exploration, emphasizing the importance of ground truthing and geochemical/geophysical data in delineating robust drill targets. The interview also covers their "scout drilling campaign" and the anticipation of assay results. Cooper Metals' expansion into new tenements near the Eloise Deposit and plans for the future are highlighted, and their commitment to keeping stakeholders informed remains a key focus throughout the conversation.
Copyright 2023 – Finance News Network
23 Jul 2020 - Noxopharm Limited (ASX:NOX) Executive Chairman and CEO Dr Graham Kelly discusses important pre-clinical results for the company's programs.
25 Sep 2023 - Wally Graham of Resources Roadhouse at the New World Metals Conference, speaking with Iggy Tan, Managing Director of Altech Batteries (ASX:ATC).
19 Sep 2022 - Altech Chemicals Limited (ASX:ATC) Managing Director Iggy Tan discusses the advantages of the company's sodium alumina solid state batteries over lithium-ion batteries, and the roadmap ahead to commercialisation.
10 Sep 2019 - Cashwerkz Limited (ASX:CWZ) Director, John Nantes talks FY19 results and outlook, including growth in distribution through adviser platforms, neo-banks and new functionality.
03 Feb 2020 - Embark Ventures Managing Partner Michael Curtis provides an update on talks about the company's role as investment manager for MMJ Group Holdings (ASX:MMJ), the Canadian cannabis market and what’s planned for the portfolio.
08 Dec 2021 - Altech Chemicals Limited (ASX:ATC) Managing Director Iggy Tan discusses the cracking of the "silicon barrier" in order to significantly increase the energy retention and capacity of lithium-ion batteries for electric vehicles.
31 Mar 2021 - Recce Pharmaceuticals Limited (ASX:RCE, FSE:R9Q) CEO and Managing Director James Graham talks about progress with the company's lead anti-infective candidate Recce 327, its expanding portfolio of synthetic anti-infectives targeting viral pathogens and a broad range of bacteria, clinical trial results and priorities for 2021.
2 Aug 2022 - Laybuy Holdings Limited (ASX:LBY) Co-Founder and Managing Director Gary Rohloff discusses quarterly results, restructuring of the company and outlook.
